Deepcyte
Health
· Headquartered in Denmark 🇩🇰
Track Deepcyte
— get Health deals in free daily digest
Overview
Deepcyte, a techbio company specializing in AI-driven toxicology for drug development, has launched with $1.5 million in seed funding. This funding will help advance its single-cell analysis platform and predictive AI tools, addressing challenges in drug development.
Products
Loading...
Synthesising company profile
Reading press coverage to extract founders, customers, traction signals and competitive positioning…
Recent Announcements
Deepcyte, a techbio company specializing in AI-driven toxicology for drug development, has launched with $1.5 million in seed funding. This funding will help advance its single-cell analysis platform and predictive AI tools, addressing challenges in drug development.